All relevant data are within the manuscript and its Supporting Information files. All sequencing data files are available from the NCBI's Gene Expression Omnibus database (accession number GSE89051).

Introduction {#sec001}
============

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal (non-epithelial) tumors of the gastrointestinal tract, with a majority of cases localized in stomach (55.6%) and small intestine (31.8%) \[[@pone.0209342.ref001],[@pone.0209342.ref002]\]. GISTs are considered to arise from interstitial cells of Cajal and are characterized by expression of tyrosine kinase receptor protein KIT (CD117)--the main diagnostic marker for these tumors \[[@pone.0209342.ref003]\]. Activating mutations in *KIT* proto-oncogene and homologous *PDGFRA* receptors result in constitutive activation of these proteins and are crucial initiating events in GIST pathogenesis. Although the key aspects of GIST pathogenesis are already elucidated, the mechanisms underlying overexpression of oncogenes and the role of gene expression regulators, like non-coding RNAs, in development of GISTs are not well investigated, yet.

Long intergenic non-coding RNAs (lincRNAs) are long (\>200 nucleotides) non-coding RNAs that do not overlap exons of protein coding genes and comprise more than half of human long non-coding RNAs (lncRNAs) \[[@pone.0209342.ref004]\]. In recent years these non-coding RNAs emerged as important regulators of multiple cellular and molecular processes such as alternative splicing, chromatin modifications, transcriptional and post-transcriptional regulation, mRNA activity, stability and degradation and were found to be implicated in pathogenesis of diseases and development of cancer \[[@pone.0209342.ref004],[@pone.0209342.ref005]\]. For example, the extensively studied lincRNA metastasis-associated lung adenocarcinoma transcript 1 *(MALAT1*) is overexpressed in lung adenocarcinoma, breast, pancreatic, colon, prostate, and hepatocellular carcinomas while promoting cell proliferation and metastasis \[[@pone.0209342.ref005],[@pone.0209342.ref006]\]. Another lincRNA, Imprinted Maternally Expressed Transcript *H19*, has been shown to act both as tumor suppressor and oncogene in different types of cancer, playing an important role in epithelial mesenchymal transition and tumor growth and is a precursor of oncogenic microRNA miR-675 \[[@pone.0209342.ref007]--[@pone.0209342.ref010]\]. LncRNAs can also interact with small non-coding RNAs, i.e. acting as competing endogenous RNAs and sponging microRNAs through their binding sites \[[@pone.0209342.ref011]\]. In this way, lncRNAs can suppress microRNAs from binding to their targets and modulate target gene expression or be regulated by microRNAs.

Up to now, only two lncRNAs---*HOTAIR* and *CCDC26*---were investigated in GIST in more detail and were associated with high risk grade, metastasis and sensitivity to a drug imatinib \[[@pone.0209342.ref012]--[@pone.0209342.ref014]\]. Therefore, in this study we aimed to investigate lincRNAs deregulated in GIST and find new GIST-lincRNA associations. We performed next-generation sequencing data analysis and validated expression of three deregulated and cancer associated lincRNAs--*MALAT1*, *H19* and *FENDRR*--in GIST and adjacent tissues. Further analysis revealed correlations between overexpressed investigated lincRNAs in GIST tissue and genes involved in GIST pathogenesis, as well as with GIST deregulated microRNAs.

Materials and methods {#sec002}
=====================

Clinical samples, RNA material, gene expression and sequencing data {#sec003}
-------------------------------------------------------------------

Paired formalin-fixed, paraffin-embedded (FFPE) tumor and adjacent tissue samples from 37 patients (total 74 samples) diagnosed with GIST of gastric origin were included in this study. The study group consisted of 22 women and 15 men with the average age of 66.95 (SD ± 12.39). GIST diagnosis was based on GIST morphology and positive KIT (CD117) immunohistochemical staining. Risk grade of tumors was assessed according to National Institutes of Health (NIH) GIST Consensus Criteria \[[@pone.0209342.ref015]\]. GIST patients included in the study were classified as: 7 high risk grade, 11 moderate, 15 low and 4 very low risk grade. Based on the GIST histological subtype, the majority of tumors in this study were of spindle cell type (n = 26), with several cases of epithelioid (n = 7) and mixed spindle and epithelioid (n = 4) cell type. *KIT* and *PDGFRA* mutational status was verified for 32 patients: 18 patients had *KIT* gene mutations exon 11 (n = 17), and exon 9 (n = 1), 9 patients had *PDGFRA* gene mutations in exon 18 (n = 6) and exon 12 (n = 3), while 5 patients were *KIT/PDGFRA* wild type. Distribution of all evaluated parameters did not differ in discovery and validation cohorts (p-value \> 0.05). Fisher's exact test was used for qualitative measurements and *t*-test was used for quantitative measurements.

RNA and DNA material was extracted from FFPE tissue samples using commercial miRNeasy FFPE and Qiamp FFPE DNA tissue Kits (Qiagen) following manufacturers recommendations.

Small RNA sequencing data (HiSeq2500, Illumina) of paired samples from 15 GIST patients was used for primary detection of deregulated lincRNAs (discovery cohort), while validation cohort for lincRNA expression analysis consisted of 22 patients' paired samples. RNA libraries were prepared for sequencing using TruSeq Small RNA Sample Preparation Kit (Illumina).

More detailed characteristics of patients, GIST mutational status, RNA/DNA extraction, library preparation and NGS sequencing methods, as well as detailed methodology of *KIT*, *PDGFRA*, *ETV1* and microRNA gene expression analysis were described in our previous publication \[[@pone.0209342.ref016]\]. Small RNA sequencing data can be accessed at NCBI's Gene Expression Omnibus (series accession number GSE89051).

The study was approved by the Kaunas Regional Biomedical Research Ethics Committee (No. BE-2--8). All patients have signed an informed consent form to participate in the study.

lincRNA sequencing data analysis {#sec004}
--------------------------------

Sequencing data analysis was performed using web-based tool miRMaster \[[@pone.0209342.ref017]\], where preprocessed sequencing reads (after adapter trimming, quality filtering and read collapsing) were mapped against the NONCODE 2016 database \[[@pone.0209342.ref018]\] of lncRNAs, using default parameters. P-values were generated by Kruskal-Wallis test and used for evaluation of gene expression changes after Benjamini-Hochberg adjustment for multiple testing. Changes with an adjusted probability value below 0.05 were considered as significant.

Validation of lincRNA expression by reverse transcription quantitative real-time PCR (RT-qPCR) {#sec005}
----------------------------------------------------------------------------------------------

Paired RNA samples of 22 GIST patients (total 44 samples) were included in the lincRNA expression validation cohort. RNA was reverse transcribed using High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). Expression of lincRNAs *MALAT1*, *H19* and *FENDRR* in GIST tumor and adjacent tissues was measured using commercial TaqMan Gene Expression Assays (Hs00273907_s1 for *MALAT1*; Hs00399294_g1 for *H19*; Hs05044154_s1 for *FENDRR*) and TaqMan Universal PCR Master Mix on the 7500 Fast Real-Time PCR system, according to the manufacturer's protocol. Gene expression data was normalized to the expression levels of *GAPDH* housekeeping gene (Hs99999905_m1) and analyzed using comparative CT method.

Statistical analysis {#sec006}
--------------------

Differences between means of lincRNA expression validation data were analyzed using paired Student's t-test. Expression changes with a Bonferroni adjusted p-values lower than 0.05 were considered significant. Spearman's correlation analysis was applied on log~2~(2^-dCt^) values. Correlation coefficient values were assigned to groups from "negligible correlation" to "very high positive (negative) correlation" according to Mukaka M. \[[@pone.0209342.ref019]\]. LincRNA-oncogene and lincRNA-microRNA expression correlations were considered significant with a p-value lower than 0.01.

Kruskal-Wallis multiple comparisons test was applied to investigate differences of lincRNA expression in different GIST phenotypes. P-values lower than 0.05 were considered significant.

All statistical analyses were performed using the statistical computing environment R (version 3.4.4) \[[@pone.0209342.ref020]\].

Results {#sec007}
=======

LincRNA analysis using NGS data {#sec008}
-------------------------------

Sequences were mapped to a total 7240 lincRNA transcripts from the NONCODE database. After application of selection criteria (Benjamini-Hochberg adjusted p-value \< 0.05, 2 \< log~2~FC \< -2), 23 lincRNA transcripts (9 unique lincRNAs) were significantly deregulated in GIST tissue compared to adjacent tissue, with six lincRNAs being upregulated and three---downregulated ([Table 1](#pone.0209342.t001){ref-type="table"}).

10.1371/journal.pone.0209342.t001

###### Significantly deregulated lincRNA transcripts in GIST vs. GIST adjacent tissue (paired samples of 15 patients) obtained from small RNA sequencing data.

![](pone.0209342.t001){#pone.0209342.t001g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Transcript          lincRNA           p-value       Benjamini-Hochberg adjusted\                    Fold Change, GIST vs. adjacent tissue   Log~2~(FC), GIST vs. GIST adjacent tissue
                                                      p-value[^a^](#t001fn001){ref-type="table-fn"}                                           
  ------------------- ----------------- ------------- ----------------------------------------------- --------------------------------------- -------------------------------------------
  ENST00000447298.1   H19               1.13×10^−6^   0.002                                           69.2                                    6.1

  ENST00000428066.5   H19               1.13×10^−6^   0.002                                           68.9                                    6.1

  ENST00000442037.5   H19               1.42×10^−6^   0.002                                           61.2                                    5.9

  ENST00000446406.5   H19               2.99×10^−6^   0.002                                           34.2                                    5.1

  ENST00000414790.5   H19               2.99×10^−6^   0.002                                           34.1                                    5.1

  ENST00000412788.5   H19               2.99×10^−6^   0.002                                           34.0                                    5.1

  ENST00000431095.5   H19               3.66×10^−6^   0.002                                           33.9                                    5.1

  ENST00000422826.1   H19               2.99×10^−6^   0.002                                           33.9                                    5.1

  ENST00000411754.5   H19               3.66×10^−6^   0.002                                           33.8                                    5.1

  ENST00000439725.5   H19               3.66×10^−6^   0.002                                           33.7                                    5.1

  ENST00000417089.5   H19               3.66×10^−6^   0.002                                           33.7                                    5.1

  ENST00000582452.1   LINC00908         4.99×10^−5^   0.016                                           33.3                                    5.1

  ENST00000598996.2   FENDRR            2.20×10^−5^   0.011                                           15.8                                    4.0

  ENST00000519898.5   CARMN             1.18×10^−4^   0.028                                           11.1                                    3.5

  ENST00000610481.1   MALAT1            2.34×10^−4^   0.046                                           8.2                                     3.0

  ENST00000544868.2   MALAT1            3.28×10^−5^   0.012                                           6.6                                     2.7

  ENST00000508832.2   MALAT1            1.47×10^−4^   0.034                                           6.0                                     2.6

  ENST00000534336.1   MALAT1            8.87×10^−5^   0.022                                           5.3                                     2.4

  ENST00000619449.1   MALAT1            8.55×10^−5^   0.022                                           5.0                                     2.3

  ENST00000637098.1   LINC00862         8.29×10^−5^   0.022                                           4.6                                     2.2

  ENST00000582320.2   AC024267.1--201   6.26×10^−5^   0.019                                           0.1                                     -2.9

  ENST00000607097.1   AC084346.2--201   4.58×10^−6^   0.002                                           0.1                                     -3.2

  ENST00000413053.2   MIR194-2HG        3.67×10^−5^   0.013                                           0.01                                    -6.6
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ The difference is significant when Benjamini-Hochberg adjusted p-value is \< 0.05.

FC--fold change

Overexpression of lincRNAs *MALAT1*, *H19* and *FENDRR* verified in an independent group of GIST patients {#sec009}
---------------------------------------------------------------------------------------------------------

Since the NGS analysis was based on small RNA sequencing, we further validated differential expression of lincRNAs in an independent group of 22 GIST patients (paired GIST and adjacent tissue samples), using RT-qPCR analysis. Three lincRNAs--*MALAT1*, *H19* and *FENDRR* shown to be significantly deregulated in GIST vs. adjacent tissue in our NGS data and previously associated with oncogenic processes, were selected for this validation step. Gene expression analysis results were in line with NGS data. All three investigated lincRNAs were upregulated in GIST tissue compared to adjacent tissue ([Fig 1](#pone.0209342.g001){ref-type="fig"} and [S1 Table](#pone.0209342.s001){ref-type="supplementary-material"}). Significant upregulation was observed in expression levels of *H19* and *FENDRR*, with fold changes 25.8 (Bonferroni adjusted p-value = 3.70×10^−11^) and 4.7 (Bonferroni adjusted p-value = 4.66×10^−4^), respectively; while *MALAT1* was overexpressed nominally (1.7-fold, Bonferroni adjusted p-value = 0.141).

![LincRNAs *FENDRR*, *H19* and *MALAT1* expression in GIST vs. adjacent tissue (paired samples of 22 patients).\
\* p-value \< 0.05 (Bonferroni adjusted p-value); whiskers--min. and max. values. LincRNA expression was normalized to expression levels of *GAPDH*.](pone.0209342.g001){#pone.0209342.g001}

Correlation analysis of *MALAT1*, *H19*, *FENDRR* and GIST associated oncogenes {#sec010}
-------------------------------------------------------------------------------

To examine potential effects of changes in lincRNAs expression on GIST pathogenesis, association analysis between lincRNAs and GIST associated oncogenes *KIT*, *PDGFRA* and *ETV1* was performed. Expression data of *KIT*, *PDGFRA* and *ETV1* has been previously described \[[@pone.0209342.ref016]\] and all three genes were shown to be significantly overexpressed in GIST tissue of our study group. High positive correlation was observed between expression levels of *ETV1* and *H19* (r = 0.74, p = 1.2×10^−7^) ([Fig 2A](#pone.0209342.g002){ref-type="fig"}, [S2](#pone.0209342.s002){ref-type="supplementary-material"} and [S3](#pone.0209342.s003){ref-type="supplementary-material"} Tables), while expression levels between *H19* and *KIT* or *PDGFRA*, *MALAT1* and *PDGFRA*, *FENDRR* and *KIT* or *ETV1* correlated moderately (r-values between ±0.5 and ±0.7, p-value \< 0.01) ([Fig 2B--2F](#pone.0209342.g002){ref-type="fig"}, [S2](#pone.0209342.s002){ref-type="supplementary-material"} and [S3](#pone.0209342.s003){ref-type="supplementary-material"} Tables).

![Significant correlations between expression levels of lincRNAs and GIST associated oncogenes *KIT*, *ETV1* and *PDGFRA*.\
(A) High positive correlation between *H19* and *ETV1*, (B-F) Moderate correlation scatter plots. r--Spearman's rank correlation coefficient; correlation is significant when p \< 0.01.](pone.0209342.g002){#pone.0209342.g002}

Correlation analysis of *MALAT1*, *H19*, *FENDRR* and microRNAs differentially expressed in GIST {#sec011}
------------------------------------------------------------------------------------------------

Since it has been shown that lncRNAs can interact with other non-coding RNAs and participate in regulation of tumorigenic processes, lincRNA-microRNA correlation analysis was performed using expression data of 19 microRNAs, shown to be differentially expressed in GIST tissue compared to adjacent tissue in our previous study \[[@pone.0209342.ref016]\]. Spearman's correlation test revealed high positive correlation between *H19* and miR-455-3p (r = 0.74, p = 3.1×10^−5^) ([Fig 3B](#pone.0209342.g003){ref-type="fig"}, [S2](#pone.0209342.s002){ref-type="supplementary-material"} and [S3](#pone.0209342.s003){ref-type="supplementary-material"} Tables), while expression of miR-133a-3p, miR-133b, miR-486-5p, miR-203a-3p, miR-182-5p, miR-675-3p, and miR-483-5p correlated moderately with expression levels of *H19* (r-values between ±0.5 and ±0.7, p-value \< 0.01) ([Fig 3A](#pone.0209342.g003){ref-type="fig"}, [S2](#pone.0209342.s002){ref-type="supplementary-material"} and [S3](#pone.0209342.s003){ref-type="supplementary-material"} Tables). Significant moderate positive correlations were also observed between *FENDRR* and miR-455-3p, miR-675-3p, miR-483-5p (0.5 \< r \< 0.7, p-value \< 0.01). *MALAT1* showed only low or no correlation with microRNAs differentially expressed in GIST ([Fig 3A](#pone.0209342.g003){ref-type="fig"}, [S2](#pone.0209342.s002){ref-type="supplementary-material"} and [S3](#pone.0209342.s003){ref-type="supplementary-material"} Tables).

![Correlation of lincRNAs and microRNAs.\
(A) Correlogram of GIST deregulated validated microRNAs and lincRNAs *FENDRR*, *H19* and *MALAT1*. The size and color intensity of the circle reflects the strength of Spearman correlation. (B) Significant high positive correlation between lincRNA *H19* and miR-455-3p. Spearman's correlation coefficient and p value are shown in the plot.](pone.0209342.g003){#pone.0209342.g003}

*MALAT1*, *H19*, *FENDRR* and GIST phenotype association analysis {#sec012}
-----------------------------------------------------------------

To investigate possible clinical significance of validated lincRNAs in GIST (validation group n = 22 patients), subphenotype analysis based on histological types (spindle cell type (n = 14), epithelioid cell type (n = 4), mixed spindle and epithelioid cell type (n = 4)), disease risk grade (high (n = 3), moderate (n = 7), low (n = 9) and very low grade (n = 3)) and GIST mutational status (*KIT* mutant (n = 9), *PDGFRA* mutant (n = 6), *KIT/PDGFRA* wild type (n = 2)) was performed ([S4 Table](#pone.0209342.s004){ref-type="supplementary-material"}). However, multiple group comparison analyses did not reveal any significant differences in expression levels of *MALAT1*, *H19* or *FENDRR* between different histological subtypes, GIST risk grades or *KIT/PDGFRA* mutational status ([S4](#pone.0209342.s004){ref-type="supplementary-material"} and [S5](#pone.0209342.s005){ref-type="supplementary-material"} Tables).

Discussion {#sec013}
==========

Although a number of studies have elucidated the importance of lncRNAs in regulation of various biological processes and development of diseases, their profile and role in pathogenesis of GISTs are scarcely investigated. In the present study, we determined the profile of lincRNAs -a subset of lncRNAs--deregulated in GISTs. Further, we examined expression of three upregulated lincRNAs in a bigger group of independent patients and investigated associations with changes in expression of GIST-associated oncogenes and GIST-deregulated microRNAs.

Analysis of NGS data revealed 9 unique and strongly deregulated lincRNAs in gastric GIST tissue compared to adjacent gastric tissue. Among the top deregulated lincRNAs, three previously cancer associated lincRNAs---*MALAT1*, *H19* and *FENDRR*, were significantly upregulated in a discovery cohort. *MALAT1* and *H19* have been mostly described as oncogenic lincRNAs. Their overexpression, contributing to cell proliferation, metastasis, epithelial mesenchymal transition and poor prognosis, has been observed in esophageal squamous cell carcinoma, osteosarcoma, colorectal, gastric and other cancer types \[[@pone.0209342.ref006],[@pone.0209342.ref008],[@pone.0209342.ref021]--[@pone.0209342.ref025]\]. However, in our replication study only *H19* showed significant 25.8-fold overexpression in GIST tissue, while *MALAT1* was slightly overexpressed, but did not reach the required significance level. Both NGS and validation cohorts indicated *FENDRR* to be overexpressed in gastric GIST. Previous studies indicated *FENDRR* to be downregulated in a number of cancers, including osteosarcoma, gastric, breast, prostate cancers, and to be negatively associated with higher tumor stage, deeper invasion, shorter overall survival, suppression of apoptosis, promotion of cell proliferation and migration \[[@pone.0209342.ref026]--[@pone.0209342.ref029]\], but has been strongly overexpressed in an infantile hemangioma \[[@pone.0209342.ref030]\]. Furthermore, another study has shown that FENDRR was co-expressed with KIT--an oncogene crucial in GIST development--in a gallbladder cancer \[[@pone.0209342.ref031]\]. These findings are consistent with our results, where FENDRR expression significantly correlated with expression of KIT, and could explain the strong overexpression of FENDRR in GIST. However, the mechanisms of possible interactions between FENDRR and KIT have not been described yet and more thorough examination is needed in order to determine the role of these oncogenic molecules.

LincRNAs may affect expression of the coding genes through a variety of mechanisms such as regulation of chromatin, scaffolding RNA and proteins or acting as protein and RNA decoys \[[@pone.0209342.ref004]\]. Therefore, we tested possible correlations between differentially expressed lincRNAs and GIST-associated oncogenes. Analysis revealed a high positive correlation between expression levels of *H19* and *ETV1*. ETV1 is an ETS family transcription factor, which is highly expressed in all GISTs and is crucial for GIST growth and survival \[[@pone.0209342.ref032]\]. It has been shown that ETV1 is stabilized by another GIST-associated oncogene tyrosine kinase receptor KIT through the MAP kinase signaling pathway and they together form a positive feedback circuit to regulate GIST tumorigenesis \[[@pone.0209342.ref032],[@pone.0209342.ref033]\]. Interestingly, another study revealed that *H19* might increase phosphorylation levels of components of MAP kinase pathway, such as pMEK and pERK, in colorectal cancer \[[@pone.0209342.ref034]\]. Moreover, a moderate, but significant correlation was observed between expression levels of *H19* and *KIT* or *PDGFRA* oncogenes in our study. This supports the theory of the positive feedback circuit between KIT and ETV1 \[[@pone.0209342.ref033]\], and the possible role of PDGFRA in stabilizing ETV1 \[[@pone.0209342.ref035]\]. These findings altogether suggest that *H19* might be an important factor in pathogenesis of GIST and is worth further investigation.

It has been reported that lncRNAs can interact with microRNAs by masking their targets' binding sites, acting as competing endogenous RNAs and "sponge" microRNAs away from their mRNA targets, interacting with other microRNA related factors or being precursors for microRNAs \[[@pone.0209342.ref004],[@pone.0209342.ref036]\]. Therefore, we used microRNA profiling data from our previous study \[[@pone.0209342.ref016]\] and evaluated their correlation with the expression of the three lincRNAs. A strong positive correlation was observed between expression levels of *H19* and miR-455-3p. Studies of this microRNA have demonstrated inconsistent results, where miR-455-3p has been shown to be overexpressed and/or have oncogenic properties in *KIT/PDGFRA* mutant GISTs and esophageal squamous cell carcinoma \[[@pone.0209342.ref037],[@pone.0209342.ref038]\], but acted as a tumor suppressor in melanoma, pancreatic and non-small cell lung cancers \[[@pone.0209342.ref039]--[@pone.0209342.ref041]\]. Both *H19* and miR-455-3p were shown to be involved in the regulation of cancer related p53 signaling \[[@pone.0209342.ref042],[@pone.0209342.ref043]\], which has been shown to be important in GIST oncogenesis, as well \[[@pone.0209342.ref044]\]. However, no direct association between *H19* and miR-455-3p could be found in literature. We also observed a moderate positive association between expression levels of oncogenic miR-675 and *H19*, as well as a moderate negative correlation between *H19* and miR-133 family members and other tumor suppressive microRNAs like miR-486-5p, miR-182-5p or miR-203a-3p \[[@pone.0209342.ref045]--[@pone.0209342.ref048]\]. MiR-675 is already known to be derived from *H19* \[[@pone.0209342.ref009],[@pone.0209342.ref049]\] and has been shown to be implicated in the development of colorectal and breast cancers \[[@pone.0209342.ref050],[@pone.0209342.ref051]\], while both miR-203a and *H19* have been shown to interact with E2F Transcription factor 1 (E2F1) \[[@pone.0209342.ref052]--[@pone.0209342.ref054]\]. This transcription factor is essential for cell proliferation \[[@pone.0209342.ref055]\] and can be upregulated by H19 in pancreatic ductal adenocarcinoma \[[@pone.0209342.ref054]\] or contrarily activates the promoter of H19 in breast cancer cells \[[@pone.0209342.ref053]\]. Furthermore, E2F1 binds to the promoter and activates miR-203a, while miR-203a can decrease expression of E2F1 through inhibition of CDK6, forming a feed-back loop \[[@pone.0209342.ref052]\]. Direct interactions between moderately correlated *H19* and miR-182, miR-486 or miR-133b have also been previously predicted from Argonaute-crosslinking and immunoprecipitation (AGO-CLIP) data \[[@pone.0209342.ref056]\] and requires additional experimental validation. As for the other identified correlations between *H19* or *FENDRR* and deregulated microRNAs no data has been found in the literature. Therefore, future studies are needed in order to confirm possible links between these oncogenic molecules and identify their interaction mode and possible role in oncogenesis.

We are aware that our study has certain limitations that need to be acknowledged. Firstly, due to the limited availability of fresh-frozen samples, FFPE samples were used for lincRNA and gene expression analyses in this study. Although, higher levels of RNA degradation can occur in FFPE tissues, previous studies have demonstrated that FFPE tissue can be a feasible material for gene expression analysis \[[@pone.0209342.ref057]\]. Secondly, we performed lincRNA profile analysis on small-RNA sequencing data. The purified RNA from FFPE is highly affected by hydrolysis and is fragmented into small (on average 100 nucleotide long) sequences \[[@pone.0209342.ref058]--[@pone.0209342.ref060]\]. These RNA fragments contain 5'-PO~4~ and 3'-OH end groups, which are used for selective ligation of sequencing adapters in Illumina Truseq small RNA sequencing protocol. Due to these features of FFPE-purified RNA (length and the end groups), small RNA-seq is sufficient to detect long non-coding RNAs in FFPE samples. However, to ensure the reliability of sequencing results, the findings were additionally validated by RT-qPCR method. We also admit that further functional experiments are needed to confirm the role of investigated lincRNAs in GISTs.

In summary, we performed lincRNA expression profile analysis in GISTs and confirmed significant overexpression of *H19* and *FENDRR* in GIST tissue compared to adjacent non-cancerous tissue. Association analyses revealed strong correlations between expression levels of lincRNA *H19* and GIST-related oncogene *ETV1* and cancer associated miR-455-3p. Despite the limitations described above, lincRNAs *MALAT1*, *H19* and *FENDRR* were not previously investigated in GISTs and we believe that our findings expand the knowledge in GISTs biology and elucidate possibly important components of GIST tumorigenesis for future studies.
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